California Public Employees Retirement System Harvard Bioscience Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$6.98 - $8.47 $169,586 - $205,787	-24,296 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$5.44 - $8.4 $538,255 - $831,129	-98,944 Reduced 80.29%	24,296 $202,000
Q1 2020 May 12, 2020	SELL	$1.42 - $3.29 $22,666 - $52,514	-15,962 Reduced 11.47%	123,240 $272,000
Q3 2017 Nov 15, 2017	BUY	$2.7 - $3.75 $375,845 - $522,007	139,202	139,202 $522,000

Others Institutions Holding HBIO

# of Institutions

Shares Held

30.6M

Call Options Held

700

Put Options Held

2.1K

Black Rock Inc. New York, NY

2.84M
Shares

$6.09 Million
0.0% of portfolio
Punch & Associates Investment Management, Inc. Edina, MN

2.77M
Shares

$5.93 Million
0.44% of portfolio
Harvey Partners, LLC Tarrytown, NY

2.72M
Shares

$5.81 Million
0.87% of portfolio
Amh Equity LTD

2.39M
Shares

$5.11 Million
8.88% of portfolio
Vanguard Group Inc Valley Forge, PA

2.15M
Shares

$4.61 Million
0.0% of portfolio

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $89.1M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account